Pediatrix Medical Group, Inc.: current accounts payable
Pediatrix Medical Group current accounts payable: $37.2 million at 2025-12-31, down 19.8% on the year. 16 values since 2010, each linked to its SEC filing.
All Pediatrix Medical Group, Inc. financial histories
At a glance
Pediatrix Medical Group reported current accounts payable of $37.2 million at 2025-12-31, down 19.8% from $46.4 million a year earlier. From 2010 to 2025 it grew at a compound 9.5% a year, from $9.58 million to $37.2 million. Across the last five reported years it ranged from $31.9 million (2022-12-31) to $46.4 million (2024-12-31). That was 1.7% of total assets ($2.25 billion) at the same date.
Computed from the values in the table below, in USD; each links to the filing it came from.
What this measure means
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
Exact concept: us-gaap:AccountsPayableCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| - | 2025-12-31 | 37,220,000 | USD | 2026-02-19 | 10-K · 0001193125-26-058074 SEC |
| - | 2024-12-31 | 46,431,000 | USD | 2026-02-19 | 10-K · 0001193125-26-058074 SEC |
| - | 2023-12-31 | 34,588,000 | USD | 2025-02-20 | 10-K · 0000950170-25-023730 SEC |
| - | 2022-12-31 | 31,857,000 | USD | 2024-02-20 | 10-K · 0000950170-24-016794 SEC |
| - | 2021-12-31 | 36,645,000 | USD | 2023-02-17 | 10-K · 0000950170-23-003127 SEC |
| - | 2020-12-31 | 59,771,000 | USD | 2022-02-17 | 10-K · 0000950170-22-001387 SEC |
| - | 2019-12-31 | 35,410,000 | USD | 2021-02-18 | 10-K · 0001193125-21-047064 SEC |
| - | 2018-12-31 | 31,059,000 | USD | 2020-02-20 | 10-K · 0001193125-20-042622 SEC |
| - | 2017-12-31 | 34,632,000 | USD | 2019-02-14 | 10-K · 0001193125-19-040891 SEC |
| - | 2016-12-31 | 28,474,000 | USD | 2018-02-14 | 10-K · 0001193125-18-045748 SEC |
| - | 2015-12-31 | 21,969,000 | USD | 2017-02-10 | 10-K · 0001193125-17-038250 SEC |
| - | 2014-12-31 | 32,783,000 | USD | 2016-02-11 | 10-K · 0001193125-16-459842 SEC |
| - | 2013-12-31 | 18,605,000 | USD | 2015-02-09 | 10-K · 0001193125-15-039201 SEC |
| - | 2012-12-31 | 13,812,000 | USD | 2014-02-12 | 10-K · 0001193125-14-045903 SEC |
| - | 2011-12-31 | 12,264,000 | USD | 2013-02-15 | 10-K · 0001193125-13-062738 SEC |
| - | 2010-12-31 | 9,581,000 | USD | 2012-02-29 | 10-K · 0001193125-12-089192 SEC |
Related Pediatrix Medical Group, Inc. histories
Inspect the source
- Entity
- Pediatrix Medical Group, Inc. / CIK 0000893949
- Captured
- SEC response SHA-256
cd5e403d5ef27c5a875148f892cd1ce579acb050821877bc2acfefac482790a2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000893949.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))